Investing.com - Quest Diagnostics (NYSE:DGX) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Quest Diagnostics announced earnings per share of $3.76 on revenue of $2.72B. Analysts polled by Investing.com anticipated EPS of $3.74 on revenue of $2.66B.
Quest Diagnostics shares are up 9% from the beginning of the year, still down 3.38% from its 52 week high of $134.57 set on February 1. They are under-performing the S&P 500 which is up 11.11% from the start of the year.
Quest Diagnostics follows other major Healthcare sector earnings this month
Quest Diagnostics's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.33 on revenue of $22.01B.
Abbott Labs had beat expectations on Tuesday with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar